医药职业洞察与研究

World Management Team in office silhouette 3d rendering

Drug Development

The Gap Between the Administration’s Pro-Innovation Words and Policy

July 14, 2025

6 min read

IN PARTNERSHIP WITH PATSNAP

Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter

June 25, 2025

1 min read

Policy

The Memory Gap: How Forgotten Diseases Are Making a Dangerous Comeback

May 19, 2025

6 min read

PARTNERED

Where AI Adds Real Value in Clinical Development

May 12, 2025

7 min read

In partnership with GenScript

Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies

April 14, 2025

6 min read

IN PARTNERSHIP WITH DIA

Beyond Neutrality: How Nonprofit Organizations Drive Healthcare Innovation and Collaboration

April 7, 2025

7 min read

LATEST PODCASTS

Podcast

Sarepta’s Wild Week, CDER’s New Leader, FDA Rejections, Manufacturing Billions

Sarepta Therapeutics faces serious FDA action after news broke of a third patient death, the FDA gets a new top drug regulator in George Tidmarsh, a handful of new drugs get turned away from the market and pharma companies continue to commit billions to reshoring manufacturing.

July 23, 2025

1 min read

Jef Akst

IN PARTNERSHIP WITH ECLIPSEBIO

Why Countries Are Racing To Build mRNA Factories While America Hesitates on Next-Gen Vaccines

In this episode presented by Eclipsebio, BioSpace’s head of insights Lori Ellis continues the discussion on mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines and Pad Chivukula of Arcturus Therapeutics.

July 22, 2025

1 min read

IN PARTNERSHIP WITH IQVIA

AI Is Taking Over Drug Safety Monitoring–But There’s One Thing It Can’t Replace

In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the evolving role of local qualified persons for pharmacovigilance with ⁠Ana Pedro Jesuíno⁠, global head local QPPV network at IQVIA.

July 17, 2025

1 min read

Job Trends

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

GSK, Sail, BioNTech Cut Staff for Second Time This Year

Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.

July 21, 2025

164 min read

BioSpace Editorial Staff

Job Trends

Report: U.S. Life Sciences Job Market Report Q2 2025

July 17, 2025

1 min read

Modern tower buildings in financial district on sunny day in Chicago

Job Trends

6 Companies Hiring in Illinois

July 17, 2025

1 min read

Illustration showing hands removing pieces of pie chart

Job Trends

Adapting in Uncertain Times: Biopharma Professionals Turn To Fractional Roles

July 17, 2025

6 min read

Job Trends

Bonus Episode: Q1 2025 Job Market Update

July 15, 2025

1 min read

DEALS

AbbVie's office in South San Francisco, California

Cancer

AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B

The deal, which involves a $700 million upfront payment, gives AbbVie access to ISB 2001, a clinical-stage first-in-class trispecific antibody currently being tested for certain kinds of multiple myeloma as well as autoimmune indications.

July 10, 2025
·
1 min read
·
Dan Samorodnitsky
Gene therapy

AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M

The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR Pharmaceuticals for use in up to five of Alexion’s gene therapies.

July 9, 2025
·
1 min read
·
Dan Samorodnitsky
M&A

Merck Makes Big Respiratory Play With $10B Acquisition of Verona

In the second biggest acquisition of the year, Merck gains the commercial COPD drug Ohtuvayre, which could help offset the loss of revenue when Keytruda’s patent expires later this decade.

July 9, 2025
·
2 min read
·
Tristan Manalac
Weight loss

Novo Nordisk’s Termination of Hims & Hers Deal Reignites Compounding Row

Analysts said the deal with Novo was likely giving Hims “‘credibility’ or increased consumer traffic,” adding that the “litigation risk is back on the table” now that the Danish pharma has stepped away.

July 9, 2025
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions

Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout

The deal marks an end for CAR T company Cargo Therapeutics, which has been slashing its workforce and cutting programs since the January decision to halt its lead candidate for a certain type of aggressive large B cell lymphoma.

July 8, 2025
·
1 min read
·
Annalee Armstrong

WEIGHT LOSS

Podcast

FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease

Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees and tying review times to drug prices; the regulator opens its trove of complete response letters in the name of transparency; and two companies receive rejections for rare disease therapies.

July 16, 2025
·
1 min read
·
Heather McKenzie
Obesity

Hengrui’s Dual GLP-1/GIP Elicits 17.7% Weight Loss in Phase III

The molecule, developed in collaboration with Massachusetts-based Kailera Therapeutics, is headed for a new drug application in China and global clinical trials.

July 15, 2025
·
2 min read
·
Dan Samorodnitsky
Obesity

Obesity in Focus: ADA Reveals R&D Priorities for Blockbusters-in-Waiting

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next generation of weight loss medicines: muscle preservation, limited side effects and novel targets.

July 14, 2025
·
9 min read
·
Tristan Manalac
Podcast

Second Half Milestones, KalVista’s Surprise Approval, Another RFK Jr. Lawsuit, More

H2 2025 catalysts to watch, biopharma implications of President Trump’s tax law, KalVista’s new hereditary angioedema drug that Marty Makary reportedly tried to reject, another lawsuit aimed at Health Secretary Robert F. Kennedy Jr. and a plea from patients with ALS for access to BrainStorm’s NurOwn.

July 9, 2025
·
1 min read
·
Heather McKenzie
Drug Development

5 Second-Half Biopharma Milestones To Watch

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in 2025, according to Jefferies.

July 7, 2025
·
8 min read
·
Tristan Manalac

POLICY

L-R: Deb Bellina, Mitze Klingenberg, Nicole Cimbura, Lorri Cavalierre, Kandy Simons, Rebecca Andrews

ALS

Patients Fight for Access to BrainStorm’s ALS Drug After Expanded Access Data ‘Defy Logic’

Participants in trials of BrainStorm Cell Therapeutics’ NurOwn filed a Citizens’ Petition with the FDA earlier this month seeking a new review of the stem cell therapy that was rejected in 2022 based on real-world data and 90% survival in an expanded access program.

July 17, 2025
·
9 min read
·
Heather McKenzie
Layoffs

HHS Begins Formally Laying Off Employees

Thousands of employees across HHS were terminated Monday evening after the U.S. Supreme Court ruled last week that the Trump administration could move forward with its sweeping reorganization of the agency.

July 15, 2025
·
2 min read
·
Tristan Manalac
Policy

FDA Commissioner Marty Makary Proposes Lowering Industry User Fees

According to Makary, reducing user fees—which make up just under half of the FDA’s budget—could make it easier for smaller companies, individual investors and academics to participate in the process.

July 15, 2025
·
2 min read
·
Tristan Manalac
Drug Development

The Gap Between the Administration’s Pro-Innovation Words and Policy

Despite the FDA commissioner’s promises of partnership and collaboration, personnel changes and continued federal cuts create uncertainty for an industry already struggling with nearly half a decade of investment scarcity.

July 14, 2025
·
6 min read
·
Lori Ellis
FDA

FDA Rejections: We Read 200 CRLs So You Don’t Have To

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli Lilly’s Alzheimer’s antibody Kisunla, Sarepta’s DMD gene therapy Vyondys 53 and Gilead’s HIV drug Sunlenca.

July 11, 2025
·
5 min read
·
Annalee Armstrong

CAREER HUB

Businessman balancing on seesaw with thumb up and thumb down

Career Advice

When Feedback Feels Off: Using Critique That Doesn’t Feel Fair

It’s easy to get caught up in defending yourself against critique that feels unfair. Leadership coach Angela Justice recommends a different approach that can help you better align how you want to be seen with how you’re showing up.

July 16, 2025

3 min read

Angela Justice

Pictured: Office building science collage

Career Advice

The Top 12 Companies Hiring in Biopharma Now

July 3, 2025

1 min read

Illustration of chart showing decrease against background of map

Job Trends

Thanks, But No Thanks: Biopharmas Hiring Less International Talent

June 26, 2025

4 min read

Collage illustration showing hand holding magnifying glass over location

Job Search Strategy

Finding Your Next Role: 5 Ways To Uncover Hidden Jobs

Tapping into the hidden job market can be challenging but is important in today’s employer-driven market. Three talent acquisition experts share tips for accessing hard-to-find roles.

June 25, 2025

5 min read

Illustration of red paper plane leading white paper planes up into the sky

Career Advice

Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs

In the latest installment of his column, Kaye/Bassman’s Michael Pietrack shares five ways leaders can help their teams after a layoff, from acknowledging emotions to reestablishing culture.

June 25, 2025

4 min read

Michael Pietrack

Aerial panorama of Trenton New Jersey skyline and state capitol at sunset. Trenton is the capital city of the U.S. state of New Jersey and the county seat of Mercer County.

Job Trends

9 Companies Hiring in New Jersey

Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.

June 12, 2025

1 min read

Chantal Dresner

Illustration showing a handshake, signaling cooperation, goodwill

Career Advice

Everyone Talks About Making a First Impression, But What About Your Last One?

Whether you’re moving on or being moved out, how you leave can shape your reputation more than how you led.

May 29, 2025

4 min read

Angela Justice

Job Trends

2025 Q1 Job Market Report: Quarterly Job Postings Live Declined as Applications Spiked

Year-over-year BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the first quarter of 2025.

May 8, 2025

3 min read

Illustration showing knowledge sharing between two people

Leadership

Leadership Lab: 9 Tips for Fully Benefiting From an Executive Coach

Learn how to extract the full value from executive coaching, starting with being open and honest with your coach.

April 30, 2025

4 min read

Michael Pietrack

HOTBEDS

Biotech Bay

Biotech Beach

Genetown

Pharm Country

BioMidwest

BioForest

BioCapital

Bio NC

Lone Star Bio

The Best Places to Work in Life Sciences in 2025

Where are the Best Places to Work in life sciences? BioSpace’s annual Best Places to Work list demonstrates a company’s desirability in the recruitment marketplace - find out who made the list this year.

May 23, 2024

View 2025 Winners

IN CASE YOU MISSED IT

A silhouetted roller coaster, taken on high speed black and white film for dramatic effect.

Duchenne muscular dystrophy

Sarepta Craters as FDA Considers Requesting Halt to Elevidys Shipments

The rollercoaster week for Sarepta Therapeutics continued, with shares of the embattled gene therapy-turned-siRNA biotech down 37% Friday afternoon as media outlets reported FDA plans to request a stop to all shipments of the Duchenne muscular dystrophy therapy Elevidys following a third patient death linked to the underlying platform.

July 18, 2025

2 min read

Heather McKenzie

vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake

Clinical research

BMS’ Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial

July 18, 2025

2 min read

Tristan Manalac

A person and a group of people are separated by a yellow line. Establishing contact. Distrust. Quarantine. Distance with strangers. Barrier to understanding, difficult integration. Rejection, refusal.

Cancer

GSK’s Blenrep Loses Adcomm Vote, Further Clouding Comeback Bid

July 18, 2025

2 min read

Tristan Manalac

REPORTS

Employer Resources

Report: 2025 Employment Outlook

In this Employment Outlook report, BioSpace explores current workforce sentiment, job activity trends and the prospective job and hiring outlook for 2025, particularly as it compares to the previous year.

January 28, 2025

1 min read

Job Trends

Report: 2025 U.S. Life Sciences Salary Report

March 25, 2025

1 min read

Pictured: Silhouettes of people on report cover

Employer Resources

Report: The State of Diversity, Equity, Inclusion and Belonging in Life Sciences

BioSpace’s third report on diversity, equity, inclusion and belonging in life sciences examines dramatic shifts in attitude around diversity initiatives.

May 6, 2024

1 min read